- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.03. | Nasdaq Stockholm AB: New equity right for trading, Ziccum AB TO5 (114/24) | 172 | GlobeNewswire | At the request of Ziccum AB, Ziccum AB equity rights will be traded on First
North Growth Market as from March 7, 2024.
Security name: Ziccum AB TO5
-----------------------------
Short name: ZICC... ► Artikel lesen | |
| 29.02. | Nasdaq Stockholm AB: Delising of paid subscription units of Ziccum AB from First North Growth Market (100/24) | 230 | GlobeNewswire | Last day of trading in paid subscription units (BTA) of Ziccum AB
Trading in Ziccum AB paid subscription units is to cease. The last trading day
is March 1, 2024.
Short name: ZICC BTU
---------------------------
ISIN... ► Artikel lesen | |
| 30.01. | Nasdaq Stockholm AB: Listing of unit rights and subscription units of Ziccum AB (44/24) | 271 | GlobeNewswire | With effect from January 31, 2024, the unit rights in Ziccum AB will be traded
on First North Growth Market. Trading will continue up until and including
February 09, 2024.
Instrument: Unit rights... ► Artikel lesen | |
| 26.01. | Ziccum AB: Year-End report Q4 2023 | 363 | GlobeNewswire (Europe) | YEAR-END REPORT Q4 2023: 1 JANUARY - 31 DECEMBER 2023
Significant events during the QuarterCollaboration agreement with University of CopenhagenOn December 4th, the company announced that it had signed... ► Artikel lesen | |
| 26.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 26.01.2024 | 554 | Xetra Newsboard | Das Instrument 4DX GB00BJTCG679 DX (GROUP) PLC LS -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 26.01.2024 und ex Kapitalmassnahme am 29.01.2024 The instrument 4DX GB00BJTCG679 DX (GROUP) PLC LS... ► Artikel lesen | |
| 21.12.23 | Ziccum AB: CEO's Seasons Greetings 2023: A pivotal year of significant results | 72 | GlobeNewswire (Europe) | At the end of an exciting and eventful year, Ziccum CEO Ann Gidner summarizes the milestones reached, the robust Ziccum Strategic roadmap underpinning them and looks forward to a busy and dynamic 2024.
Dear... ► Artikel lesen | |
| 09.05.23 | Ziccum signs Evaluation Agreement with Biopharmaceutical Corporation focused on mRNA technologies | 315 | GlobeNewswire (Europe) | Ziccum AB (publ) ('Ziccum') has signed an Evaluation agreement with a Biopharmaceutical Corporation focused on mRNA technologies to commence a Feasibility study regarding LaminarPace for ambient drying... ► Artikel lesen |
7 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 27,180 | -0,51 % | Fresenius: Aktie knackt Hürde - wichtige Termine voraus | Die Aktie von Fresenius kommt immer mehr in Fahrt. Am heutigen Montag gewinnt das Papier weitere 1,2 Prozent auf 27,21 Euro, nachdem Fresenius in den vergangenen Wochen bereits deutlich zulegen konnte.... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,30 | -0,87 % | DAX im Minus, Nahost-Lage spitzt sich zu: Rheinmetall, Lufthansa, Siemens Healthineers, TUI ... | Nachdem der DAX am Donnerstag noch freundlich mit einem Plus von 0,4 Prozent auf 17.837,40 Zählern aus dem Handel gegangen war, zeichnet sich für den letzten Handelstag der Woche ein kräftiges Minus... ► Artikel lesen | |
| THERMO FISHER | 534,00 | +0,17 % | Thermo Fisher: Dauerläufer-Aktie beeindruckt erneut | Die amerikanische Life-Science-Aktie Thermo Fisher gehört zu den Unternehmen, die in der Historie wesentlich besser gelaufen sind als der S&P 500. An diesem Trend sollte sich langfristig nichts ändern.... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 57,28 | -0,35 % | Eurofins Scientific SE: Eurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its Objectives | Regulatory News:
The Eurofins (Paris:ERF) network of companies continues to deliver resilient growth:
Reported revenues in Q1 2024 totalled €1,653m, an increase of 5.0% vs Q1 2023, driven... ► Artikel lesen | |
| SYNLAB | 10,500 | -0,38 % | EQS-DD: SYNLAB AG: Prof. Dr. David Ebsworth, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
19.04.2024 / 10:04... ► Artikel lesen | |
| DAVITA | 124,00 | +0,16 % | DaVita Set To Achieve 100% Renewable Energy Consumption Goal By 2025 | WASHINGTON (dpa-AFX) - Kidney care services provider DaVita (DVA) said Monday it expects to match 100% of its electricity use across its global operations with renewable energy purchases by... ► Artikel lesen | |
| DENTSPLY SIRONA | 28,380 | +0,28 % | S&P Dow Jones Indices: GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600 | NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600:
Solventum Corp. (NYSE: SOLV) will be added... ► Artikel lesen | |
| SMITH & NEPHEW | 11,560 | +3,31 % | SMITH & NEPHEW PLC - 6-K, Report of foreign issuer | ||
| SONIC HEALTHCARE | 16,150 | -0,01 % | SONIC HEALTHCARE LIMITED: Change in substantial holding | ||
| DIASORIN | 95,30 | +1,40 % | DiaSorin jumps after BofA restarts with 'buy' rating | ||
| FULGENT GENETICS | 18,700 | 0,00 % | Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
| PATTERSON COMPANIES | 23,800 | -1,65 % | Dividendenbekanntmachungen (18.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSA GROUP LIMITED ADR US00400T1025 0,5706 USD 0,5347 EUR AKER ASA NO0010234552 15,5 NOK 1,3202 EUR ANORA GROUP OYJ FI4000292438 - 0... ► Artikel lesen | |
| IMPLANTICA | 2,280 | -3,18 % | Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module) | VADUZ, Liechtenstein, March 27, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the submission of the... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 1,500 | +0,67 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results | SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout... ► Artikel lesen | |
| OMNICELL | 25,400 | 0,00 % | Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen |
Das Unternehmen ZICCUM AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -3,35 % bei einem Aktienkurs von 0,520 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
